Acrobiosystems (SHE:301080) will invest 150 million yuan as a limited partner in a new venture capital fund, according to a Thursday filing with the Shenzhen bourse.
The amount is equivalent to 30% of the 500-million-yuan Suzhou Su-High-Tech Rongsheng ACRO Venture Capital Partnership.
The fund will have a duration of eight years. It will invest in upstream life science tools and services, biopharmaceuticals, medical devices, and biomanufacturing, the filing said.
The biopharmaceutical company's shares fell 9% during the afternoon session on Thursday.